Analysen von James Gordon
02.11.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
06.10.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
31.03.16 | Roche overweight | JP Morgan Chase & Co. | |
08.12.15 | MorphoSys overweight | JP Morgan Chase & Co. |
02.11.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
06.10.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
31.03.16 | Roche overweight | JP Morgan Chase & Co. | |
08.12.15 | MorphoSys overweight | JP Morgan Chase & Co. |